MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Issuance of common stockunder atm$6K something is missing$2K Net cash provided byfinancing activities$6K (-99.92%↓ Y/Y)Canceled cashflow$2K Net increase in cash-$4,149K (-260.44%↓ Y/Y)Canceled cashflow$6K Stock-based compensation$320K (-63.22%↓ Y/Y)Other non-currentassets-$85K (-8400.00%↓ Y/Y)Impairment of goodwill$44K Amortization of right-of-useasset$35K (-60.67%↓ Y/Y)Issuance of common stockto consultant for...$24K (-74.19%↓ Y/Y)Other receivables-$12K (95.76%↑ Y/Y)Depreciation andamortization$9K (-74.29%↓ Y/Y)Fee related to theexercise of prefunded...$2K Net cash used inoperating activities-$4,152K (9.68%↑ Y/Y)Canceled cashflow$529K Cash used ininvesting activities-$3K Net loss-$4,015K Accounts payable andaccrued expenses-$394K (14.90%↑ Y/Y)Other liabilities-$94K (-174.02%↓ Y/Y)Prepaid expenses andother current assets$59K (-56.93%↓ Y/Y)Gain onextinguishment of contingent...$41K Operating lease liability-$40K (56.04%↑ Y/Y)Purchase of property andequipment$3K
Cash Flow

Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Inc. (ERNA)

source: myfinsight.com